[1] |
Afshin A, Forouzanfar MH, Reitsma MB, et al. Health Effects of Overweight and Obesity in 195 Countries[J]. N Engl J Med, 2017, 377(15): 13-27.
|
[2] |
Leblanc ES, O'Connor, Whitlock EP, et al. Effectiveness of primary care-relevant treatments for obesity in adults: a systematic evidence review for the U.S. Preventive Services Task Force[J]. Annals of Internal Medicine, 2011, 155(7): 434-447.
|
[3] |
Curioni CC, Lourenco PM. Long-term weight loss after diet and exercise: a systematic review[J]. International Journal of Obesity, 2005, 29(10): 1168-1174.
|
[4] |
Rucker D, Padwal R, Li SK, et al. Long term pharmacotherapy for obesity and overweight: updated meta-analysis[J]. Bmj British Medical Journal, 2007, 335(7631): 1194-1199.
|
[5] |
Davies MJ, Bergenstal R, Bode B, et al. Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes[J]. JAMA, 2015, 314(7): 687.
|
[6] |
Melissas J, Stavroulakis K, Tzikoulis V, et al. Sleeve Gastrectomy vs Roux-en-Y Gastric Bypass. Data from IFSO-European Chapter Center of Excellence Program[J]. Obesity Surgery, 2016, 27(4): 847-855.
|
[7] |
Bray GA, Heisel WE, Afshin A, et al. The Science of Obesity Management: An Endocrine Society Scientific Statement[J]. Endocrine Reviews, 2018, 39(2): 79-132.
|
[8] |
Takachi K, Doki Y, Ishikawa O, et al. Postoperative ghrelin levels and delayed recovery from body weight loss after distal or total gastrectomy[J]. Journal of Surgical Research, 2006, 130(1): 1-7.
|
[9] |
Hosoda H, Kojima M, Kangawa K. Biological, physiological, and pharmacological aspects of ghrelin[J]. J Pharmacol Sci, 2006, 100(5): 398-410.
|
[10] |
Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans[J]. J Clin Endocrinol Metab, 2001, 86(12): 5992.
|
[11] |
Esler WP, Rudolph J, Claus TH, et al. Small-Molecule Ghrelin Receptor Antagonists Improve Glucose Tolerance, Suppress Appetite,and Promote Weight Loss[J]. Endocrinology, 2007, 148(11): 5175-5185.
|
[12] |
Cummings DE, Weigle DS, Frayo RS, et al. Plasma Ghrelin Levels after Diet-Induced Weight Loss or Gastric Bypass Surgery[J]. New England Journal of Medicine, 2002, 346(21): 1623-1630.
|
[13] |
Druce MR, Small CJ, Bloom SR. Minireview: Gut peptides regulating satiety[J]. Endocrinology, 2004, 145(6): 2660-2665.
|
[14] |
Murray CDR, Kamm MA, Bloom SR, et al. Ghrelin for the gastroenterologist: history and potential[J]. Gastroenterology, 2003, 125(5): 1492-1502.
|
[15] |
Arepally A, Barnett BP, Montgomery E, et al. Catheter-directed gastric artery chemical embolization for modulation of systemic ghrelin levels in a porcine model: initial experience[J]. Radiology, 2007, 244(1): 138-143.
|
[16] |
Bawudun D, Xing Y, Liu WY, et al. Ghrelin Suppression and Fat Loss after Left Gastric Artery Embolization in Canine Model[J].CardioVascular and Interventional Radiology, 2012, 35(6): 1460-1466.
|
[17] |
Fu Y, Weiss CR, Paudel K, et al. Bariatric Arterial Embolization: Effect of Microsphere Size on the Suppression of Fundal Ghrelin Expression and Weight Change in a Swine Model[J]. Radiology, 2018, 00: 1-8.
|
[18] |
Kim JM, Kim MD, Han K, et al. Bariatric Arterial Embolization with Non-spherical Polyvinyl Alcohol Particles for Ghrelin Suppression in a Swine Model[J]. Cardiovasc Intervent Radiol, 2017, 40(5): 744-749.
|
[19] |
Pasciak AS, Bourgeois AC, Paxton BE, et al. Bariatric Radioembolization: A Pilot Study on Technical Feasibility and Safety in a Porcine Model[J]. Journal of Vascular & Interventional Radiology Jvir, 2016, 27(10): 1509-1517.
|
[20] |
Paxton BE, Arepally A, Alley CL, et al. Bariatric Embolization: Pilot Study on the Impact of Gastroprotective Agents and Arterial Distribution on Ulceration Risk and Efficacy in a Porcine Model[J]. J Vasc Interv Radiol, 2016, 27(12): 1923-1928.
|
[21] |
Arepally A, Barnett BP, Patel TH, et al. Catheter-directed gastric artery chemical embolization suppresses systemic ghrelin levels in porcine model.[J]. Radiology, 2008, 249(1): 127-133.
|
[22] |
Diana M, Pop R, Beaujeux R, et al. Embolization of Arterial Gastric Supply in Obesity (EMBARGO): an Endovascular Approach in the Management of Morbid Obesity. Proof of the Concept in the Porcine Model[J]. Obesity Surgery, 2015, 25(3): 550-558.
|
[23] |
Gunn A J, Oklu R. A preliminary observation of weight loss followingleft gastric artery embolization in humans[J].J Obes, 2014, 2014: 185349.
|
[24] |
Anton K, Rahman T. Weight Loss Following Left Gastric Artery Embolization in a Human Population without Malignancy: A Retrospective Review[J]. Journal of Obesity & Weight Loss Therapy, 2015, 05(06):1-4.
|
[25] |
Kipshidze N, Archvadze A, Bertog S, et al. Endovascular Bariatrics: First in Humans Study of Gastric Artery Embolization for Weight Loss[J]. Jacc Cardiovasc Interv, 2015, 8(12): 1641-1644.
|
[26] |
Syed MI, Morar K, Shaikh A, et al. Gastric Artery Embolization Trial for the Lessening of Appetite Nonsurgically (GET LEAN): Six-Month Preliminary Data.[J]. Journal of Vascular & Interventional Radiology, 2016, 27(10): 1502-1508.
|
[27] |
Weiss CR, Akinwande O, Paudel K, et al. Clinical Safety of Bariatric Arterial Embolization: Preliminary Results of the BEAT Obesity Trial[J]. Radiology, 2017, 283(2): 598-608.
|
[28] |
Bai ZB, Qin YL, Deng G, et al. Bariatric Embolization of the Left Gastric Arteries for the Treatment of Obesity: 9-Month Data in 5 Patients[J]. Obes Surg, 2018, 28(4): 907-915.
|
[29] |
Arepally A, Barnett BP, Patel TH, et al. Catheter-directed gastric artery chemical embolization suppresses systemic ghrelin levels in porcine model[J]. Radiology, 2008, 249(1): 127-133.
|
[30] |
Kim JM, Kim MD, Han K, et al. Bariatric Arterial Embolization with Non-spherical Polyvinyl Alcohol Particles for Ghrelin Suppression in a Swine Model[J]. Cardiovascular & Interventional Radiology, 2017, 40(5): 744-749.
|
[31] |
Fink JM, Martini V, Seifert G, et al. Left Gastric Artery Embolization for Weight Loss—a Dead-End Procedure[J]. Obesity Surgery, 2018, 28(11): 3623-3624.
|
[32] |
Trujillo M R, Muller D, Widmer J D, et al. Long-Term Follow-Up of Gastric Banding 10 Years and Beyond[J].Obesity Surgery, 2016, 26(3): 581-587.
|